HFA Premium Access

Design and baseline characteristics of REALIZE K: a placebo-controlled randomized-withdrawal trial of sodium zirconium cyclosilicate for hyperkalaemia management in patients with HF and reduced EF

Congress Presentation

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations
9 followers

9 more presentations in this session

Effect of IV iron in patients with heart failure with preserved ejection fraction

Speaker: Professor S. von Haehling (Goettingen, DE)

Thumbnail

Discussant review - FAIR-HFpEF

Speaker: Professor P. Kalra (Portsmouth, GB)

Thumbnail

Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme

Speaker: Professor M. Petrie (Glasgow, GB)

Thumbnail

Discussant review - STEP HFpEF Program

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Thumbnail

Discussant review - REALIZE-K

Speaker: Professor G. Rosano (London, GB)

Thumbnail

Access the full session

Late breaking clinical trials: further analyses and baseline characteristics

Speakers: Doctor M. Kosiborod, Professor S. von Haehling, Professor P. Kalra, Professor M. Petrie, Doctor A. Bayes Genis...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations